hepatitis b

Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980), a synthetic peptide analog, specifically binds to Hep G2 cells and is a potential immunogen expected to induce protective antibodies through the attachment blockade pathway of virus neutralization [1] [2].

Hepatitis B Virus Pre-S Region (120-145) is a preS2 peptide that effectively blocks the attachment of single-chain Fv fragment (scFv) or IgG to recombinant Hepatitis B surface antigen (r-HBsAg) [1].

[Ala127] Hepatitis B Virus Pre-S Region (120-131) is a peptide with the sequence MQWNSTAFHQT, potentially useful for studies on activity enhancement [1].

The hepatitis B virus (HBV) core protein has been found in the nucleus, the cytoplasm, or both of HBV-infected hepatocytes. nuclear localization of the HBV core protein is negatively regulated by phosphorylation during the cell cycle.

HBcAg (core antigen) is a hepatitis B viral protein. It is an indicator of active viral replication; this means the person infected with Hepatitis B can likely transmit the virus on to another person.

Cyclosporin B is an immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection. Cyclosporin B displays antiviral properties, inhibiting the entry of hepatitis B into hepatocytes. Cyclosporin B also

HBV Seq2 aa:28-39, a Hepatitis B surface antigen (HBsAg) peptide, specifically binds to Major Histocompatibility Complex (MHC) class I molecules, as evidenced in sources [1] [2].

HBV Seq2 aa:208-216, a CD8 epitope peptide derived from HBsAg, is investigated within the context of the Large envelope protein from the Hepatitis B virus [1].

HBV Seq2 aa:179-186, a novel epitope located on the hepatitis B virus surface antigen, effectively serves as a motif for CTL response within the H-2b system following in vitro restimulation of primed T cells [1].

HBV Seq1 aa:93-100 is a peptide fragment of the hepatitis B virus (HBV) core antigen spanning amino acids 93 to 100 [1].

HBV Seq1 aa:63-71 is a fragment of the hepatitis B virus (HBV) [1].

HBV Seq1 aa:18-27 is a hepatitis B virus (HBV) core antigen peptide fragment spanning amino acids 18-27 [1].

HBV Seq1 aa:141-151 is a peptide useful for chronic hepatitis B virus (HBV) research [1].

HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV properties, shown to enhance antibody titers after hepatitis B vaccination. Its potential in viral infection treatment warrants further investigation [1].